Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans
Author:
Publisher
Elsevier BV
Subject
Cellular and Molecular Neuroscience,Pharmacology
Reference276 articles.
1. Lysergic acid diethylamide (LSD-25): XVII. Tolerance development and its relationship to a theory of psychosis;Abramson;J. Psychol.,1956
2. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide);Abramson;Arch. Neurol. Psychiatry,1958
3. A roadmap for academic health centers to establish good laboratory practice-compliant infrastructure;Adamo;Acad. Med.,2012
4. Rapid substitution procedure for intravenous drug self-administration studies in rhesus monkeys;Aigner;Pharmacol. Biochem. Behav.,1979
5. Non-clinical studies in the process of new drug development - Part II: good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies;Andrade;Braz. J. Med. Biol. Res.,2016
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Drug discrimination learning: Interoceptive stimulus control of behavior and its implications for regulated and dysregulated drug intake;Pharmacology Biochemistry and Behavior;2024-11
2. Navacaprant, a novel and selective kappa opioid receptor antagonist, has no agonist properties implicated in opioid-related abuse;Neuropharmacology;2024-10
3. Single administration of a psychedelic [(R)-DOI] influences coping strategies to an escapable social stress;Neuropharmacology;2024-07
4. A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids;Frontiers in Psychiatry;2024-06-10
5. Optimizing real-world benefit and risk of new psychedelic medications: the need for innovative postmarket surveillance;Nature Mental Health;2024-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3